Just listened to the latest presentation, seems it gives reason for optimism.  One thing I found interesting though is that I seem to remember McCaffrey saying prior to the Zenith reorganization that one of the reasons for the reorg was that there would be no further dilution of ZCC and the potential RVX royalties.  He then of course went back on that and sold dilutive ZCC shares to Eastern but again said something about no more dilutiuon of ZCC at the last AGM and that further investment deals would be made in Zenith Epigenetics directly and therefore not be dilutive to ZCC.  This latest potential 10MM share sale seems like it will be once again in and dilutive to ZCC.  Someone please correct me if I am wrong in my recollection.